PROGRAMMA DEFINITIVO
Homepage SIF
37° Congresso Nazionale
President Letter
Comitati del Congresso
Temi del congresso
Programma Comunicazioni Orali
Programma Sessioni Poster
Simposi
Letture
Informazioni Scientifiche
Informazioni Generali
Seminario Dottorandi e Assegnisti
Status Abstracts
E.C.M.
Scadenze e Download
Privacy
Sessioni Simposi
Pharmacovigilance and Risk Management Strategies
Martedì 27 Ottobre 2015
14.00-15.30
The clinical pharmacology of heart failure: general aspects and special situations (SIF-ITAHFA joint Symposium)
Martedì 27 Ottobre 2015
15.00-17.00
Therapeutic cannabis
Martedì 27 Ottobre 2015
15.30-17.00
Immuno-oncology: future perspectives in solid tumor treatment
Martedì 27 Ottobre 2015
16.00-17.00
Retinal diseases: the appropriate governance challenges
Mercoledì 28 Ottobre 2015
11.00-12.00
Diabetes: improvement of the care pathways and evaluation of direct and indirect costs (SIF-AMD-ISPOR Italy Rome Chapter-SIMG Joint Symposium)
Mercoledì 28 Ottobre 2015
11.00-13.00
From the past to the future of Nutraceuticals
Mercoledì 28 Ottobre 2015
11.00-12.30
Position papers on biosimilars
Mercoledì 28 Ottobre 2015
11.30-12.00
Multiple Sclerosis: state of the art and future perspectives (SIF-SIN joint symposium)
Mercoledì 28 Ottobre 2015
12.00-13.00
Combination therapy in controlling hypercholesterolemia and cardiovascular prevention (SIF -SITeCS joint symposium)
Mercoledì 28 Ottobre 2015
12.00-13.00
The Neuroimmune Pharmacology of Multiple Sclerosis (MS)
Mercoledì 28 Ottobre 2015
14.00-15.00
T-Cell engagement strategies: a new era for ALL (SIF-SIE joint symposium)
Mercoledì 28 Ottobre 2015
14.00-15.00
New approaches in lipid-lowering therapy (SIF-SISA joint symposium)
Mercoledì 28 Ottobre 2015
14.00-16.00
New drugs for type 2 diabetes and obesity treatment
Mercoledì 28 Ottobre 2015
14.00-16.00
Drugs with expired patent (SIF-FIMMG joint symposium)
Mercoledì 28 Ottobre 2015
14.00-15.00
The virtuous circle pharmacology-clinics: new perspectives for the treament of heart failure (SIF-FADOI joint symposium)
Mercoledì 28 Ottobre 2015
14.00-16.00
Phosphodiesterase 4 modulation in immune-mediated diseases
Mercoledì 28 Ottobre 2015
15.00-16.00
Innovation in pharmacological treatment in oncohematology (SIF-SIE joint symposium)
Mercoledì 28 Ottobre 2015
15.00-16.00
The role of adherence in the success of pharmacological treatment
Mercoledì 28 Ottobre 2015
15.30-17.30
IL-17-mediated inflammation and its clinical manifestations
Mercoledì 28 Ottobre 2015
16.00-17.00
"Which willingness to pay?"
Mercoledì 28 Ottobre 2015
16.00-17.30
Pathophysiology and pharmacology of the FPR2 receptor and its ligands
Mercoledì 28 Ottobre 2015
16.00-17.30
Industry-academia partnerships: are we ready to meet?
Mercoledì 28 Ottobre 2015
16.00-17.30
Drugs in primary care
Mercoledì 28 Ottobre 2015
17.00-19.00
Research and development of orphan drugs (SIF-SSFA joint symposium)
Mercoledì 28 Ottobre 2015
17.30-19.00
Advances in retinal pharmacology and clinical perspectives (SIF-SIR Joint Symposium)
Mercoledì 28 Ottobre 2015
17.30-19.00
Alzheimer's disease and anti-Amyloid β immunotherapy clinical studies. A critical review (SIF-SINDEM joint symposium)
Mercoledì 28 Ottobre 2015
17.30-19.00
Old and new drugs in the modulation of reward and emotional behavior
Mercoledì 28 Ottobre 2015
17.30-19.00
Targeting Inflammation to Reduce CVD Risk: a Realistic Clinical Prospect? (Joint Symposium of the British Pharmacological Society (BPS) and the Italian Society of Pharmacology (SIF) with the contribute of the Federation of European Pharmacological Societies (EPHAR))
Mercoledì 28 Ottobre 2015
8.30-10.00
The purinergic system as a new, promising target to treat human diseases (SIF-Italian Purine Club Joint Symposium)
Mercoledì 28 Ottobre 2015
8.30-10.00
TRP channels and other targets
Mercoledì 28 Ottobre 2015
8.30-10.00
Sarcopenia: from pathophysiology to experimental studies to define effective pharmacological approaches
Mercoledì 28 Ottobre 2015
8.30-10.00
Anti-Gram positive antibiotics for the treatment of ABSSSI: evolution is pharmacokinetic! (SIF-SIC joint symposium)
Giovedì 29 Ottobre 2015
09.00-10.00
Roundtable "New horizons in pharmacological research: between ethics and science"
Giovedì 29 Ottobre 2015
11.00-13.00
PUFA n-3: evidences in cardiovascular prevention
Giovedì 29 Ottobre 2015
14.00-15.00
Depression and cognitive symptoms: physiopathological, clinical and pharmacotherapeutic aspects
Giovedì 29 Ottobre 2015
14.00-15.00
Recent advances on rifaximin pharmacology and therapeutics: more than just a simple antibiotic (SIF-AIGO joint symposium)
Giovedì 29 Ottobre 2015
14.00-15.00
New perspectives on immunoinflammatory diseases
Giovedì 29 Ottobre 2015
14.00-15.00
The state of clinical research: criticalities and future perspectives
Giovedì 29 Ottobre 2015
14.00-16.00
How to maintain the long-term sustainability of pharmaceutical innovation: new drugs and new endopoints in oncology (SIF-AIOM joint symposium)
Giovedì 29 Ottobre 2015
14.00-16.00
HCV hot topics: clinical benefits and financial impact in Italy
Giovedì 29 Ottobre 2015
14.00-16.00
New horizons in IBD treatment: the anti-integrin therapies
Giovedì 29 Ottobre 2015
15.00-16.00
SIF-SIC joint symposium\nNew perspectives and approaches in bacterial infections management
Giovedì 29 Ottobre 2015
15.00-16.00
The impact of regional regulatory measures on biosimilars and bioequivalents adverse reactions reports
Giovedì 29 Ottobre 2015
15.00-16.15
Therapeutic appropriateness in hypertensive patient (SIF-SIIA joint symposium)
Giovedì 29 Ottobre 2015
16.00-18.00
The health and social effects of counterfeit drugs (SIF-SITOX joint symposium)
Giovedì 29 Ottobre 2015
16.00-18.00
Oncology at a crossroad: the use of biomarkers in target therapy (SIF-AIOM joint symposium)
Giovedì 29 Ottobre 2015
16.00-18.00
SIF-AIGO joint symposium\nUniqueness of biotechnological drugs development and production: regulatory, pharmacological and clinical aspects
Giovedì 29 Ottobre 2015
16.30-17.30
Understanding new molecular pathways in the pathogenesis of neuropsychiatric disorders: animal models towards translational approaches
Giovedì 29 Ottobre 2015
16.30-18.00
Therapeutics in spinal and central processing of pain and analgesia
Giovedì 29 Ottobre 2015
16.30-18.00
Food for Thought: when unbalanced diets lead to unbalanced brains
Giovedì 29 Ottobre 2015
16.30-18.00
New pharmacological approaches in the management of inflammatory processes
Giovedì 29 Ottobre 2015
8.30-10.00
New recent advances on glutamate receptors and their role in CNS
Giovedì 29 Ottobre 2015
8.30-10.00
Alzheimer's disease: key pathogenetic issues for novel therapeutic approaches
Giovedì 29 Ottobre 2015
8.30-10.00
Estrogens and pathologies associated with ageing
Giovedì 29 Ottobre 2015
8.30-10.00
Neuropsychopharmacological research today: great efforts, few candidates, frequent failures
Giovedì 29 Ottobre 2015
8.30-10.00
Circulating Extracellular Vesicles: cellular mediators, biomarkers and therapeutic tools
Giovedì 29 Ottobre 2015
8.30-10.00
Nicotine and nicotinic receptors: new advances in physiology and pharmacology
Giovedì 29 Ottobre 2015
8.30-10.00
Pharmacology Teaching
Venerdì 30 Ottobre 2015
09.00-10.30
Prevention of opioid drugs abuse
Venerdì 30 Ottobre 2015
09.00-10.30
Rational use of antibiotics in paediatry
Venerdì 30 Ottobre 2015
11.00-12.30
Overfeeding, dysmetabolism, inflammation and stress exposure as prominent actors in the drama of neuropsychiatric disorders: new insights for the development of novel therapies
Venerdì 30 Ottobre 2015
8.30-10.00
Purinergic enzymes: role in inflammatory/immune responses and therapeutic implications (SIF-ITALIAN PURINE CLUB joint symposium)
Venerdì 30 Ottobre 2015
8.30-10.30
Webmaster: Dr Federico Casale PhD - Realizzazione tecnica: Patrizio Casalengo
E-mail:
webmaster@sifweb.org
- Ultimo aggiornamento: 11 ottobre 2015